Speakers

Chris Lamanna received his Bachelor of Science at the University of Wisconsin (USA) before moving to Germany as a Fulbright Fellow where he later received his Ph.D. for his work on the diagnosis and treatment of rare lysosomal storage disorders. Chris joined Sandoz in 2012 where he has held various leadership roles to drive development strategy and regulatory policy for Biosimilar medicines. As Head of Regulatory Devices at Sandoz, Chris leads the team responsible for the submission, approval and maintenance of a diverse array of devices and combination products for both generic and biosimilar medicines.